Breaking News Instant updates and real-time market news.

BLUE

bluebird bio

$60.35

-4.05 (-6.29%)

10:16
12/01/16
12/01
10:16
12/01/16
10:16

bluebird bio BCMA CAR-T results early, but encouraging, says Piper Jaffray

Piper Jaffray analyst Joshua Schimmer noted that bluebird bio's interim data from its ongoing Phase 1 study of bb2121, the company's investigational anti-BCMA CAR-T candidate in patients with relapsed/refractory multiple myeloma, showed that four of nine patients achieved partial responses and two patients achieved stringent complete responses. While results are early, they are also encouraging, said Schimmer, who has an Overweight rating on bluebird shares.

  • 01

    Dec

  • 01

    Dec

  • 03

    Dec

  • 03

    Dec

BLUE bluebird bio
$60.35

-4.05 (-6.29%)

11/29/16
PIPR
11/29/16
NO CHANGE
PIPR
Piper sees bluebird regaining 'mojo and momentum'
After hosting management for an investor dinner, Piper Jaffray analyst Joshua Schimmer sees bluebird bio regaining its "mojo and momentum." The analyst expects a "steady stream of positive updates and derisking" starting with BCMA CAR-T data update this week and extending into optimizing LentiGlobin's profile for sickle cell and betathal in 2017. Schimmer has an Overweight rating on bluebird shares with a $95 price target. The biotechnology company closed yesterday down 5% to $60.65.
12/01/16
WELS
12/01/16
NO CHANGE
WELS
bluebird bio data positive, says Wells Fargo
After bluebird bio announced interim Phase 1 dose escalation data for its CAR T product bb2121 in patients with relapsed/refractory multiple myeloma, Wells Fargo says the data shows that the product provides "a profound benefit for patients exhausting available treatment options." Wells thinks that the product could be approved on an accelerated timetable, and it keeps an Outperform rating on the stock.
12/01/16
BMOC
12/01/16
NO CHANGE
BMOC
bluebird bio data 'impressive,' says BMO Capital
BMO Capital analyst Matthew Luchini says that bluebird bio's Phase I data for its bb2121 product in myeloma was "impressive." The analyst notes that the overall response rate was 78%, and he adds the product to his model for the company ,estimating peak sales of about $3.6B. However, he keeps a Market Perform rating on the shares, citing the approximately 25% increase in the stock in after-hours trading.
12/01/16
LEER
12/01/16
NO CHANGE
LEER
Outperform
bluebird bio data looks 'impressive,' says Leerink
Leerink analyst Michael Schmidt notes that bluebird bio (BLUE) announced first clinical data from its ongoing Phase I study of anti-BCMA CAR-T product candidate "bb2121" in relapsed/refractory multiple myeloma, and says it looks 'impressive." While he cautions that the data is still "somewhat immature," the early results justify the high level of excitement around the potential of anti-BCMA CAR-T therapy in relapsed/ refractory myeloma, as several other companies including Juno Therapeutics (JUNO), Kite Pharma (KITE) and Novartis (NVS) have stated plans to also develop anti-BCMA-CART product candidates. Schmidt reiterates an Outperform rating on bluebird bio's shares.

TODAY'S FREE FLY STORIES

M

Macy's

$32.23

-0.0615 (-0.19%)

15:29
02/22/17
02/22
15:29
02/22/17
15:29
Hot Stocks
S&P cuts Macy's to 'BBB-' from 'BBB', removes from CreditWatch »

S&P Global Ratings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$15.14

0.51 (3.49%)

15:20
02/22/17
02/22
15:20
02/22/17
15:20
Options
Square options imply 11.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

TIME

Time Inc.

$19.10

-0.3 (-1.55%)

, MDP

Meredith

15:19
02/22/17
02/22
15:19
02/22/17
15:19
Periodicals
Time Inc only entertaining bids for entire company, NY Post says »

A breakup of Time Inc…

TIME

Time Inc.

$19.10

-0.3 (-1.55%)

MDP

Meredith

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

$NSD

NASDAQ Market Internals

15:17
02/22/17
02/22
15:17
02/22/17
15:17
Technical Analysis
NASDAQ Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:17
02/22/17
02/22
15:17
02/22/17
15:17
Technical Analysis
NYSE Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPB

Campbell Soup

$59.16

0.21 (0.36%)

, KMB

Kimberly-Clark

$135.98

1.34 (1.00%)

15:16
02/22/17
02/22
15:16
02/22/17
15:16
Periodicals
Campbell Soup, Kimberly-Clark rumored as takeover targets, Kass says »

Doug Kass of TheStreet…

CPB

Campbell Soup

$59.16

0.21 (0.36%)

KMB

Kimberly-Clark

$135.98

1.34 (1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 27

    Feb

  • 19

    Mar

AOLS

Aeolus Pharmaceuticals

$0.19

-0.006 (-3.06%)

15:14
02/22/17
02/22
15:14
02/22/17
15:14
Hot Stocks
Aeolus Pharmaceuticals initiates Phase 1 study of AEOL 10150 »

Aeolus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:10
02/22/17
02/22
15:10
02/22/17
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

SA

Seabridge Gold

$11.35

-0.2 (-1.73%)

15:07
02/22/17
02/22
15:07
02/22/17
15:07
Hot Stocks
Seabridge Gold completes sale of Castle-Blackrock claims to Columbus Gold »

Seabridge Gold reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCN

Ocwen

$5.33

-0.21 (-3.79%)

15:05
02/22/17
02/22
15:05
02/22/17
15:05
Options
Ocwen options imply 15.4% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

AJRD

Aerojet Rocketdyne

$19.17

-0.16 (-0.83%)

, LLL

L-3 Communications

$168.49

-0.31 (-0.18%)

15:02
02/22/17
02/22
15:02
02/22/17
15:02
Hot Stocks
Aerojet Rocketdyne to acquire Coleman Aerospace for $15M in cash »

Aerojet Rocketdyne (AJRD)…

AJRD

Aerojet Rocketdyne

$19.17

-0.16 (-0.83%)

LLL

L-3 Communications

$168.49

-0.31 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DO

Diamond Offshore

$16.84

-0.52 (-3.00%)

15:01
02/22/17
02/22
15:01
02/22/17
15:01
Options
Diamond Offshore draws opening call writing »

Diamond Offshore draws…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCRA

Vocera

$19.91

-0.035 (-0.18%)

14:59
02/22/17
02/22
14:59
02/22/17
14:59
Conference/Events
Vocera management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 21

    Mar

PCTY

Paylocity

$36.86

0.59 (1.63%)

14:55
02/22/17
02/22
14:55
02/22/17
14:55
Conference/Events
Paylocity management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 23

    Feb

  • 27

    Feb

  • 01

    Mar

  • 02

    Mar

SCMP

Sucampo

$12.60

0.8 (6.78%)

, NILE

Blue Nile

14:55
02/22/17
02/22
14:55
02/22/17
14:55
Hot Stocks
Sucampo to replace Blue Nile in the S&P 600 as of February 23 open »

Sucampo Pharmaceuticals…

SCMP

Sucampo

$12.60

0.8 (6.78%)

NILE

Blue Nile

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

BPT

BP Prudhoe Bay

$29.68

-0.8716 (-2.85%)

14:53
02/22/17
02/22
14:53
02/22/17
14:53
Periodicals
BP Prudhoe Bay mentioned cautiously in a Seeking Alpha Pro article 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$277.39

5.16 (1.90%)

, GM

General Motors

$37.83

0.02 (0.05%)

14:52
02/22/17
02/22
14:52
02/22/17
14:52
Earnings
On The Fly: What to watch in Tesla earnings report »

Tesla (TSLA) is scheduled…

TSLA

Tesla

$277.39

5.16 (1.90%)

GM

General Motors

$37.83

0.02 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

FIT

Fitbit

$5.81

-0.23 (-3.81%)

14:51
02/22/17
02/22
14:51
02/22/17
14:51
Options
Healthy volume in FitBit weekly options ahead of earnings later today »

Healthy volume in FitBit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

TSLA

Tesla

$277.39

5.16 (1.90%)

14:50
02/22/17
02/22
14:50
02/22/17
14:50
Options
Tesla options imply 9.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

PM

Philip Morris

$104.33

-0.23 (-0.22%)

14:49
02/22/17
02/22
14:49
02/22/17
14:49
Earnings
Philip Morris raises FY17 EPS view to $4.80-$4.95 from $4.70-$4.85 »

Consensus $4.80. PMI is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBPB

Potbelly

14:46
02/22/17
02/22
14:46
02/22/17
14:46
Conference/Events
Potbelly management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 08

    Mar

APA

Apache

$55.25

-0.64 (-1.15%)

, HRL

Hormel Foods

$37.21

-0.39 (-1.04%)

14:44
02/22/17
02/22
14:44
02/22/17
14:44
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

APA

Apache

$55.25

-0.64 (-1.15%)

HRL

Hormel Foods

$37.21

-0.39 (-1.04%)

KSS

Kohl's

$41.28

-0.5 (-1.20%)

PF

Pinnacle Foods

$54.75

-0.49 (-0.89%)

CHK

Chesapeake

$5.97

-0.11 (-1.81%)

CNK

Cinemark

$43.25

0.37 (0.86%)

AMCX

AMC Networks

$57.69

1.86 (3.33%)

W

Wayfair

$41.08

0.82 (2.04%)

SFM

Sprouts Farmers Markets

$19.32

0.2 (1.05%)

TREE

LendingTree

$113.60

0.65 (0.58%)

TXMD

TherapeuticsMD

$5.56

-0.03 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 28

    Feb

  • 01

    Mar

  • 06

    Mar

  • 16

    Mar

  • 19

    Mar

  • 21

    Mar

  • 28

    Mar

  • 07

    May

  • 11

    May

TSLA

Tesla

$277.39

5.16 (1.90%)

, HPQ

HP Inc.

$16.15

0.02 (0.12%)

14:44
02/22/17
02/22
14:44
02/22/17
14:44
Earnings
Notable companies reporting after market close »

Notable companies…

TSLA

Tesla

$277.39

5.16 (1.90%)

HPQ

HP Inc.

$16.15

0.02 (0.12%)

CTRP

Ctrip.com

$47.06

1.43 (3.13%)

ETE

Energy Transfer Equity

$18.90

-0.15 (-0.79%)

LB

Labarge

RRC

Range Resources

$30.27

-0.15 (-0.49%)

SQ

Square

$15.10

0.47 (3.21%)

RIG

Transocean

$13.23

-0.245 (-1.82%)

SLCA

U.S. Silica

$59.37

1.27 (2.19%)

JACK

Jack in the Box

$107.37

-0.09 (-0.08%)

CAKE

Cheesecake Factory

$60.67

-1.16 (-1.88%)

PLKI

Popeyes

$78.73

12.61 (19.07%)

FIT

Fitbit

$5.81

-0.23 (-3.81%)

ELGX

Endologix

$6.49

-0.27 (-3.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 28

    Feb

  • 01

    Mar

  • 06

    Mar

  • 08

    Mar

  • 21

    Mar

  • 23

    Mar

  • 27

    Mar

  • 17

    Apr

I

Intelsat

$4.48

-0.19 (-4.07%)

14:41
02/22/17
02/22
14:41
02/22/17
14:41
Options
Ambitious call buying in Intelsat as shares drop off 52-week highs »

Ambitious call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

TPIV

TapImmune

$4.30

-0.1 (-2.27%)

14:38
02/22/17
02/22
14:38
02/22/17
14:38
Periodicals
TapImmune cancer vaccine efforts highlighted in Fox News affliate report »

Fox News 13 of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.